Filing Details
- Accession Number:
- 0001209191-22-024460
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-14 17:36:27
- Reporting Period:
- 2022-04-12
- Accepted Time:
- 2022-04-14 17:36:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642545 | Shockwave Medical Inc. | SWAV | Surgical & Medical Instruments & Apparatus (3841) | 270494101 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1911088 | Trinh Phung | C/O Shockwave Medical, Inc. 5403 Betsy Ross Drive Santa Clara CA 95054 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-04-12 | 700 | $210.73 | 32,171 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 158 | $211.22 | 32,013 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 348 | $212.26 | 31,665 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 200 | $214.25 | 31,465 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 500 | $216.10 | 30,965 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 100 | $217.00 | 30,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 470 | $219.08 | 30,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 500 | $220.18 | 29,895 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 100 | $221.14 | 29,795 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-12 | 100 | $222.41 | 29,695 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/10/2022.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.06 to $210.98. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The reported total includes an aggregate 75 shares the Reporting Person has acquired since her Form 4 report filed on February 24, 2022 in exempt transactions through automatic payroll deduction and purchase features of the Issuers Employee Stock Purchase Plan, which is a qualified tax-conditioned plan pursuant to Section 423 of the Internal Revenue Code.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $211.06 to $211.50. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $212.16 to $212.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $213.79 to $214.71. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $215.54 to $216.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- All reported securities were sold at a price of $217.00.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $218.57 to $219.25. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $219.62 to $220.56. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- All reported securities were sold at a price of $221.14.
- All reported securities were sold at a price of $222.41.
Billionaire Hedge Funds
